Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

por Ortendahl, Jesse D, Pulgar, Sonia J, Mirakhur, Beloo, Cox, David, Bentley, Tanya GK, Phan, Alexandria T
Publicado 2017

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

por Lewiecki, E Michael, Ortendahl, Jesse D, Vanderpuye‐Orgle, Jacqueline, Grauer, Andreas, Arellano, Jorge, Lemay, Jeffrey, Harmon, Amanda L, Broder, Michael S, Singer, Andrea J
Publicado 2019